Anti-oxidative effects of superoxide dismutase 3 on inflammatory diseases
- PMID: 31724066
- DOI: 10.1007/s00109-019-01845-2
Anti-oxidative effects of superoxide dismutase 3 on inflammatory diseases
Abstract
Free radicals and other oxidants are critical determinants of the cellular signaling pathways involved in the pathogenesis of several human diseases including inflammatory diseases. Numerous studies have demonstrated the protective effects of antioxidant enzymes during inflammation by elimination of free radicals. The superoxide dismutase (SOD), an antioxidant enzyme, plays an essential pathogenic role in the inflammatory diseases by not only catalyzing the conversion of the superoxide to hydrogen peroxide and oxygen but also affecting immune responses. There are three distinct isoforms of SOD, which distribute in different cellular compartments such as cytosolic SOD1, mitochondrial SOD2, and extracellular SOD3. Many studies have investigated the anti-oxidative effects of SOD3 in the inflammatory diseases. Herein, in this review, we focus on the current understanding of SOD3 as a therapeutic protein in inflammatory diseases such as skin, autoimmune, lung, and cardiovascular inflammatory diseases. Moreover, the mechanism(s) by which SOD3 modulates immune responses and signal initiation in the pathogenesis of the diseases will be further discussed.
Keywords: Anti-oxidative; Autoimmune diseases; Extracellular superoxide dismutase (SOD3); Skin inflammation; Therapeutic protein.
Similar articles
-
Involvement of superoxide dismutase isoenzymes and their genetic variants in progression of and higher susceptibility to vitiligo.Free Radic Biol Med. 2013 Dec;65:1110-1125. doi: 10.1016/j.freeradbiomed.2013.08.189. Epub 2013 Sep 12. Free Radic Biol Med. 2013. PMID: 24036105
-
Redox Regulation of the Superoxide Dismutases SOD3 and SOD2 in the Pulmonary Circulation.Adv Exp Med Biol. 2017;967:57-70. doi: 10.1007/978-3-319-63245-2_5. Adv Exp Med Biol. 2017. PMID: 29047081
-
Concentration/activity of superoxide dismutase isozymes and the pro-/antioxidative status, in context of type 2 diabetes and selected single nucleotide polymorphisms (genes: INS, SOD1, SOD2, SOD3) - Preliminary findings.Biomed Pharmacother. 2021 May;137:111396. doi: 10.1016/j.biopha.2021.111396. Epub 2021 Feb 23. Biomed Pharmacother. 2021. PMID: 33761612
-
Role of superoxide dismutase 3 in skin inflammation.J Dermatol Sci. 2012 Aug;67(2):81-7. doi: 10.1016/j.jdermsci.2012.06.003. Epub 2012 Jun 16. J Dermatol Sci. 2012. PMID: 22763488 Review.
-
Exploration of SOD3 from gene to therapeutic prospects: a brief review.Mol Biol Rep. 2024 Sep 13;51(1):980. doi: 10.1007/s11033-024-09919-2. Mol Biol Rep. 2024. PMID: 39269510 Review.
Cited by
-
Targeting of oncogenic signaling pathways by berberine for treatment of colorectal cancer.Med Oncol. 2020 Apr 17;37(6):49. doi: 10.1007/s12032-020-01367-9. Med Oncol. 2020. PMID: 32303850 Review.
-
The double-edged roles of ROS in cancer prevention and therapy.Theranostics. 2021 Mar 4;11(10):4839-4857. doi: 10.7150/thno.56747. eCollection 2021. Theranostics. 2021. PMID: 33754031 Free PMC article. Review.
-
Erythromycin regulates peroxisome proliferator-activated receptor γ to ameliorate cigarette smoke-induced oxidative stress in macrophages.J Thorac Dis. 2024 May 31;16(5):3051-3060. doi: 10.21037/jtd-23-1647. Epub 2024 May 24. J Thorac Dis. 2024. PMID: 38883674 Free PMC article.
-
Novel and Converging Ways of NOX2 and SOD3 in Trafficking and Redox Signaling in Macrophages.Antioxidants (Basel). 2021 Jan 25;10(2):172. doi: 10.3390/antiox10020172. Antioxidants (Basel). 2021. PMID: 33503855 Free PMC article. Review.
-
Oxidative Stress and Antioxidant Defense Mechanisms in Acute Ischemic Stroke Patients with Concurrent COVID-19 Infection.Int J Mol Sci. 2023 Nov 27;24(23):16790. doi: 10.3390/ijms242316790. Int J Mol Sci. 2023. PMID: 38069113 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous